drugset / Trial / NCT00754624
An Open-label, Multi-center, International, Three-year, Safety and Tolerability 'Follow on' Trial
Non-randomizedSingle-groupOpen-labelTreatment
Summary
Safety Follow-Up Trial to PDC-INS-0008 and MKC-TI-005
Timeline
- Start
- 2004-05
- Primary completion
- 2008-06
- Completion
- 2008-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Insulin | Protein / enzyme biologic | 15 iu | Inhaled |
| Subject | Insulin | Protein / enzyme biologic | 30 iu | Inhaled |
| Subject | Insulin | Protein / enzyme biologic | 60 iu | Inhaled |